Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study
Crossref DOI link: https://doi.org/10.1186/s12885-017-3887-z
Published Online: 2017-12-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Ruihua
Yu, Xianjun
Hao, Jihui
Wang, Liwei
Pan, Hongming
Han, Guohong
Xu, Jianming
Zhang, Yanqiao
Yang, Shujun
Chen, Jia
Ying, Jieer
Dai, Guanghai
Li, Mingyu
Begic, Damir
Lu, Brian
Shen, Lin
Funding for this research was provided by:
Celgene
